论文部分内容阅读
珀金埃尔默公司与国家新药筛选中心目前就个性化医疗项目达成了合作,双方将共建个性化药物研究平台。此次合作,双方将通过对患者样品基因组的测序,从而建立药物分析用的基因组信息,包括验证用于个性化疾病治
PerkinElmer and the National New Drug Screening Center currently have a partnership for personalized medicine that will build a platform for personalized medicine research. The partnership will allow both parties to sequence the patient’s sample genome to create genomic information for drug analysis, including validation for personalized disease management